Ms Aye Moa – The epidemiology of influenza B and benefit of QIV over TIV

Event type: 
Event date: 
Tuesday, 9 April 2019 - 1:00pm to 2:00pm
Berg Family Foundation Seminar Room, Level 6, Wallace Wurth Building, Kensington Campus, UNSW Sydney
Contact for inquiries: 
Rata Joseph, +61 (2) 9385 0900 or
Booking deadline: 

Kirby Institute Seminar Series presents

Ms Aye Moa

Ms Aye Moa

Research Fellow, Biosecurity Program, Kirby Institute

Aye Moa is a research fellow and program manager of the Biosecurity program, Kirby Institute, UNSW Medicine. She joined UNSW Sydney (School of Public Health and Community Medicine) in 2012 and the Kirby Institute in May 2018. Her PhD research focused on epidemiology and the burden of influenza B in Australia, the benefit of quadrivalent influenza vaccine and choices between vaccine options for Australia and use of epidemiologic data to predict seasonal severity before the epidemic (developing a risk-assessment tool – Flucast).


Until recent times, burden of influenza B infection has been less studied and underestimated compared to influenza A. Globally, the incidence of influenza B varies from season to season, by geographic regions and by age group. This presentation will discuss findings on a global review of influenza B, epidemiology and burden of influenza B infection in Australia, and the role of quadrivalent influenza vaccine (QIV) for influenza prevention.